Yale-New Haven Hospital
New Haven, Connecticut CT
79 studies enrolling now · 459 studies all time
What they study most
Abuse, Child, Acoustic Neuroma, Acute Coronary Syndrome (ACS), Acute Ischemic Stroke, Acute Kidney Injury, Acute Lymphoblastic Leukemia (ALL), Acute Lymphoid Leukemia, Disease (disorder), Acute Myelogenous Leukemia (AML or ANLL), Acute Myeloid Leukemia, Acute Myocardial Infarction, Adenoma, Adolescent Depression
Studies at this site
- A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II) — Recruiting now
- Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer — Recruiting now
- Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation. — Recruiting now
- IS-001 Injection in Patients Undergoing Robotic-Assisted Colorectal Surgery — Recruiting now
- LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) — Recruiting now
- Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) — Recruiting now
- A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis — Recruiting now
- EVERO Drug-coated Balloon (DCB) Randomized Trial — Recruiting now
- Emergency Department-Initiated Medications for Alcohol Use Disorder — Recruiting now
- A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for High-Grade Appendiceal and Colorectal Adenocarcinoma With Peritoneal Metastasis — Recruiting now
- SELUTION 4 De Novo Small Vessel IDE Trial — Recruiting now
- A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC) — Recruiting now
- Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging — Recruiting now
- The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs). — Recruiting now
- A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons — Recruiting now
- A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract — Recruiting now
- Cardiac Sarcoidosis Randomized Trial — Recruiting now
- A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs) — Recruiting now
- First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors — Recruiting now
- A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease — Recruiting now
- A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma — Recruiting now
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) — Recruiting now
- A Phase II Evaluation of Afatinib in Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma — Recruiting now
- Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants — Recruiting now
- Evaluating the Unmet Needs of Older Adults to Promote Functional Recovery After a Critical Illness — Recruiting now
- BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia — Recruiting now
- Adaptive Decision Support for Addiction Treatment Master — Recruiting now
- Regulation of Brain Glucose Metabolism in Type 1 Diabetes — Recruiting now
- Influence of Mavoglurant on Alcohol Craving and Drinking in Heavy Drinkers — Recruiting now
- Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation — Recruiting now
- Strategy for Improving Stroke Treatment Response — Recruiting now
- Skin Color Matching in Head and Neck Reconstructive Surgery — Recruiting now
- REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE — Recruiting now
- Digoxin In NASH (CODIN) — Recruiting now
- Blood Pressure Variability and Ischemic Stroke Outcome — Recruiting now
- Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition — Recruiting now
- Once Daily Intrapleural Enzyme Therapy in Complicated Parapneumonic Effusion or Empyema — Recruiting now
- Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT) — Recruiting now
- Anticoagulation in ICH Survivors for Stroke Prevention and Recovery — Recruiting now
- SHAPE Test for Preoperative Risk Stratification — Recruiting now
- Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET — Recruiting now
- Physician-Modified Fenestrated and Branched Aortic Endografting for TAAA — Recruiting now
- Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503 — Recruiting now
- A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer — Recruiting now
- Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis (NEC) — Recruiting now
- Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome — Recruiting now
- The Impact of Music Medicine on Preterm Brain Development and Behavior — Recruiting now
- The Stimulation To Induce Mothers Study — Recruiting now
- Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome — Recruiting now
- Optimizing Tracheal Intubation Outcomes and Neonatal Safety — Recruiting now